Auxo Firm Directory · Independent Research Profile

Accretive Partners

Accretive Partners publicly offers sell-side M&A and private capital advisory services. Its stated approach includes bilateral, targeted and broad sale processes, buyer screening, buyer-perspective diligence and support through negotiation and deal implementation.

Key takeaway

What stands out about Accretive Partners

Accretive Partners serves founder-led, emerging-growth and middle-market companies in Technology, Healthcare and Business Services. It offers M&A and private capital advisory, but the official M&A service page does not publish a universal transaction-size threshold or a standard fee schedule, success-fee percentage, minimum fee, expense policy, exclusivity term, or tail period. Securities products and investment banking services are stated to be offered through separate, unaffiliated BA Securities, LLC.[1][2][3]

What does Accretive Partners do?

Accretive Partners, LLC presents itself as a strategic advisor to founder-led, emerging-growth companies in Technology, Healthcare and Business Services. It publicly offers private capital advisory and mergers-and-acquisitions advisory services, and describes its clients as emerging-growth and middle-market companies.[1]

Accretive publicly offers private capital advisory and M&A advisory. Its private capital services include advice on growth equity and venture capital, recapitalizations, credit solutions and other strategic transactions. Its M&A service description includes buyer-perspective due diligence, potential-buyer screening and vetting, deal-process management, final negotiation and deal implementation.[1][2]

Owners comparing advisory firms can also review Auxo’s M&A advisor vs. business broker vs. investment bank comparison, advisor-selection guide, and sell-side advisor evaluation framework.

Public size / criteria information
Accretive describes its clients as emerging-growth and middle-market companies. The official M&A service page does not publish a universal revenue, EBITDA, enterprise-value, capital-raise or transaction-size threshold.[1]

What should a business owner evaluate before hiring Accretive Partners?

An owner evaluating Accretive can clarify which legal entity signs the engagement and receives fees, and when BA Securities is involved. The owner can also request the firm’s minimum and typical revenue, EBITDA, enterprise-value or capital-raise parameters; fee, retainer, expense, exclusivity and tail-period terms; and the proposed buyer universe and geographic coverage. Because Accretive describes bilateral, targeted and broad processes, the owner can ask how the alternatives would be applied to the proposed mandate. Additional diligence topics include conflicts, confidentiality, buyer outreach, management rollover and employee-retention issues.[1][2]

01

Which legal entity signs the engagement and receives fees, and when is BA Securities involved

The official website states that securities products and investment banking services are offered through BA Securities, LLC, while Accretive Partners, LLC and BA Securities are identified as separate, unaffiliated entities.[1]
02

What are the minimum and typical revenue, EBITDA, enterprise-value or capital-raise thresholds

The official M&A service page does not publish a universal revenue, EBITDA, enterprise-value, capital-raise or transaction-size threshold.[2]
03

What fees, retainers, success-fee percentages, expense reimbursements, exclusivity provisions and tail periods apply

The official M&A service page does not publish a standard fee schedule, success-fee percentage, minimum fee, expense policy, exclusivity term or tail period.[2]

What size transactions and clients does Accretive Partners focus on?

The firm’s stated focus sectors are Technology, Healthcare and Business Services. Its transaction archive also identifies activity involving AI EdTech, HR Tech, Healthcare Tech, Business Services and Vertical Software.[1][3]

The official transactions archive lists Coconote’s sale to Quizlet in December 2025, DecisionWise’s sale to TMA in May 2025, Echo Healthcare’s sale to 3B Scientific in January 2024, Axis Power’s growth-capital transaction with Banyan Growth Partners in May 2023, and Pinnacle Quality Insights’ sale to Home Care Pulse in January 2023.

In a separate announcement, Accretive stated that it acted as exclusive financial advisor to DecisionWise in its sale to TMA, a Main Capital Partners-backed company. Accretive also published an announcement concerning Home Care Pulse’s acquisition of Activated Insights and Pinnacle Quality Insight.[3][4][5]

Accretive describes a sell-side focus and offers bilateral, targeted and broad M&A process approaches. Its private capital advisory work covers growth equity and venture capital, recapitalizations, credit solutions and other strategic transactions.[1][2]

What does Accretive Partners publicly disclose about fees, process and engagement terms?

The official M&A service page does not publish a universal revenue, EBITDA, enterprise-value, capital-raise or transaction-size threshold. It also does not publish a standard fee schedule, success-fee percentage, minimum fee, expense policy, exclusivity term or tail period.

The official transactions archive identifies dates, sectors, clients, counterparties and locations but does not disclose transaction values or consideration terms for the listed examples. The official homepage and M&A service page do not state a specific geographic coverage mandate or geographic restriction for client engagements.[2][3]

Accretive’s official website states that securities products and investment banking services are offered through BA Securities, LLC, and identifies Accretive Partners, LLC and BA Securities, LLC as separate, unaffiliated entities. A FINRA firm report identifies BA Securities, LLC as CRD #153489 and SEC #8-68545 and states that BA Securities is regulated by FINRA. The official homepage does not state that Accretive Partners, LLC itself is a FINRA member or broker-dealer.[1][6]

Accretive states that it does not believe in exclusivity and may negotiate parallel deals with multiple parties. It offers a bilateral process with one bidder, a targeted process with selected strategic buyers, or a broad sale process. The firm also states that it screens and vets potential buyers and conducts buyer-perspective due diligence.[2]

Questions to ask before hiring Accretive Partners

Which legal entity signs the engagement and receives fees, and when is BA Securities involved?
The official website states that securities products and investment banking services are offered through BA Securities, LLC, while Accretive Partners, LLC and BA Securities are identified as separate, unaffiliated entities.[1]
What are the minimum and typical revenue, EBITDA, enterprise-value or capital-raise thresholds?
The official M&A service page does not publish a universal revenue, EBITDA, enterprise-value, capital-raise or transaction-size threshold.[2]
What fees, retainers, success-fee percentages, expense reimbursements, exclusivity provisions and tail periods apply?
The official M&A service page does not publish a standard fee schedule, success-fee percentage, minimum fee, expense policy, exclusivity term or tail period.[2]
Which sectors and geographies does the firm focus on for the proposed mandate?
Accretive states that its focus sectors are Technology, Healthcare and Business Services and that its team has relationships with a global network of investors, while the official homepage and M&A service page do not state a specific geographic coverage mandate or restriction.[1][2]
Can the firm provide additional closed-deal references and transaction values where permitted?
The official transactions archive lists transaction dates, sectors, clients, counterparties and locations but does not disclose transaction values or consideration terms for the listed examples.[3]
How are conflicts, buyer outreach, confidentiality, management rollover and employee-retention issues handled?
Accretive describes bilateral, targeted and broad sale processes, buyer screening and vetting, buyer-perspective due diligence, and parallel negotiations with multiple parties. These topics can be clarified for a proposed engagement.[2]

Sources & research notes

Public-source research
  1. Official website / firm overview
  2. Geography / market coverage
  3. Transaction / portfolio evidence
  4. Transaction / portfolio evidence
  5. Transaction / portfolio evidence
  6. FINRA regulatory record
Prepared and reviewed by: Auxo Capital AdvisorsEvidence standard: Public-source verification

How this profile was researched

Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.

Independent profile & regulatory context

Independent research profile

This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.

Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.

Broker-dealer and securities disclosure

Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.

Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.

Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.

Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.